Literature DB >> 2625468

Measurement of low (sub-therapeutic) phenobarbitone levels in plasma by high-performance liquid chromatography: application to patient compliance studies.

S Peaker1, A C Mehta, S Kumar, M Feely.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2625468     DOI: 10.1016/0378-4347(89)80034-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

1.  A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteers.

Authors:  E Hardy; S Kumar; S Peaker; M Feely; T Pullar
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

2.  The prediction of steady-state plasma phenobarbitone concentrations (following low-dose phenobarbitone) to refine its use as an indicator of compliance.

Authors:  T Pullar; S Kumar; H Chrystyn; P Rice; S Peaker; M Feely
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

3.  Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects.

Authors:  P A Winstanley; C R Newton; G Pasvol; F J Kirkham; E Mberu; N Peshu; S A Ward; J B Were; D A Warrell; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

4.  Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial.

Authors:  J Hill; H Bird; S Johnson
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

5.  Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment.

Authors:  J Karbwang; W Fungladda; C E Pickard; S Shires; A Hay; M Feely
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.